Tomorrow is Giving Tuesday!
We ask you to support our work because:
- Glioblastoma (GBM) is the most aggressive and complex brain tumor.
- GBM patients have a 5-year survival rate of 5.6%.
- GBM was first described in medical literature in the 1920s but only 4 drugs and 1 device have been approved since then.
The key to tackling this disease lies in research, and for too long we’ve lacked this critical insight from patients.
— Fabio Iwamoto MD, Deputy Head of Neuro-Oncology, Columbia University
OurBrainBank has collected over 10,000 data points from over 500 GBM patients in less than 2 years via our app. We're growing our dataset of patient-reported symptoms everyday. Patients are hungry for change. Scientist are keen to make progress. We need your support to move our mission forward and provide scientists with the valuable data they need.
Please give via our Facebook Fundraiser (at 8am ET sharp to double your gift), GoFundMe Charity, PayPal, or by check.
|
Help OurBrainBank by 
